XLON
SXS
Market cap5.52bUSD
Dec 03, Last price
4,142.00GBP
Name
Spectris PLC
Chart & Performance
P/E
17.64
P/S
3.17
EPS
2.35
Div Yield, %
1.94%
Shrs. gr., 5y
-2.73%
Rev. gr., 5y
-4.50%
Revenues
1.30b
-10.39%
Net income
233m
+60.39%
CFO
93m
-52.25%
Dividend
Oct 02, 202528 GBP/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Operating globally, Spectris plc specializes in the development and provision of sophisticated measurement tools and control systems. The company's operations are structured across distinct divisions: Malvern Panalytical, which focuses on advanced measurement and material characterization to boost efficiency in research, development, and production; HBK, delivering unique sensing, testing, modeling, and simulation capabilities for product innovation; Omega, offering solutions for process optimization, specialized sensors, and broad distribution channels; and Industrial Solutions, managing high-precision in-line sensing and monitoring enterprises. Its product portfolio includes particle measuring systems for monitoring contamination in pristine environments, Red Lion Controls for industrial automation enabling the connection, monitoring, and control of diverse assets, and Servomex, renowned for its gas and moisture analysis expertise. Beyond products, Spectris delivers data-driven insights, industrial test equipment, and specialized software. The company also offers a full suite of services covering sensor, instrument, and software technology, alongside comprehensive training, technical assistance, spare parts supply, calibration, and ongoing maintenance. Spectris serves a wide array of sectors, including pharmaceutical, automotive, electronics, semiconductor, technology-driven, and primary and advanced materials industries. Established in 1986, Spectris plc maintains its headquarters in London, United Kingdom.
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||